Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Affairs Study Projects Little Impact From Value-Based Purchasing, Suggests Alternatives

This article was originally published in The Gray Sheet

Executive Summary

Study finds that CMS' program will have a small financial impact on hospitals and questions whether it will work to incentivize better performance.

You may also be interested in...



Clinical Appropriateness Criteria Can Help Contain Elective Procedure Costs – NEJM

A New England Journal of Medicine article offers reasons why clinical appropriateness criteria could reduce costs and the number of patients who choose elective procedures such as total joint arthroplasty.

Many Medicare Demos Do Not Reduce Spending, CBO Reports

Medicare demonstration projects may need more careful design to meet cost-saving goals, says the Congressional Budget Office. Better methods to evaluate the success of demos are also necessary, the budget office argues in a January 2012 report.

Industry Wins Some, Loses Some In Final Value-Based Purchasing Rule

The device industry was able to wring some concessions from CMS in a new hospital inpatient value-based purchasing rule issued April 29, but the Medicare agency declined to make any special provisions for additional resources that hospitals may need to purchase newer medical technologies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel